Elevance Health, Inc. (ELV) Cash Flow Statement
Elevance Health, Inc. (ELV) generated $7.6B of operating cash flow over the twelve months to 2026-09-30, spent $1.1B on capital expenditure and had free cash flow of $6.5B, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason
ELVElevance Health, Inc.Follow ELV — free
—
Price chart with a free account
- Market cap
- 95.1B
- P/E TTM
- 18.7
- Dividend yield
- 1.6%
- 52-week
- —
- Next earnings
- 26 Jan, in 94 days
| Line | FY2009 Dec 09 | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Sep 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 3.04 | 1.42 | 3.37 | 2.74 | 3.05 | 3.37 | 4.21 | 3.27 | 4.19 | 3.83 | 6.06 | 10.69 | 8.36 | 8.40 | 8.06 | 5.81 | 4.29 | 7.60 | |
| Capital expenditure | 0.38 | 0.45 | 0.52 | 0.54 | 0.65 | 0.71 | 0.64 | 0.58 | 0.79 | 1.21 | 1.08 | 1.02 | 1.09 | 1.15 | 1.30 | 1.26 | 1.12 | -1.08 | |
| Free cash flow | 2.66 | 0.97 | 2.85 | 2.20 | 2.41 | 2.65 | 3.57 | 2.69 | 3.39 | 2.62 | 4.98 | 9.67 | 7.28 | 7.25 | 6.77 | 4.55 | 3.17 | 6.51 | |
| Dividends paid | — | — | 0.36 | 0.37 | 0.45 | 0.48 | 0.66 | 0.68 | 0.71 | 0.78 | 0.82 | 0.95 | 1.10 | 1.23 | 1.40 | 1.51 | 1.53 | — | |
| Share repurchases | 2.64 | 4.36 | 3.04 | 2.50 | 1.62 | 3.00 | 1.52 | 0.00 | 2.00 | 1.69 | 1.70 | 2.70 | 1.90 | 2.32 | 2.68 | 2.90 | 2.61 | — | |
| Stock-based compensation | 0.15 | 0.14 | 0.13 | 0.15 | 0.15 | 0.17 | 0.15 | 0.17 | 0.17 | 0.23 | 0.29 | 0.28 | 0.26 | 0.26 | 0.29 | 0.19 | 0.28 | — |
USD billions · SEC XBRL
Elevance Health, Inc. — questions
- What is Elevance Health, Inc.'s operating cash flow?
- $7.6B over the twelve months to 2026-09-30.
- How much does Elevance Health, Inc. spend on capital expenditure?
- $1.1B over the twelve months to 2026-09-30.
- What is Elevance Health, Inc.'s free cash flow?
- $6.5B over the twelve months to 2026-09-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Elevance Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.